Welcome

GMO is a global investment management firm committed to providing sophisticated clients with superior asset management solutions. Our sole business is investment management and, as a private partnership, we are accountable only to our clients and to ourselves. We forge strong partnerships with our clients, managing their money as if it were our own and offering them honest counsel. Our deep and talented investment teams are highly experienced and forward-thinking, investing with focused expertise in a wide range of asset classes.

focus-on-what-matters_trim

Investment Results: We believe that valuation-driven investing with a long horizon will achieve the best risk-adjusted returns.
In-Depth Analysis and Research: We combine rigorous fundamental analysis with innovative quantitative methods to understand the long-term drivers of returns.
Our Clients: We provide our clients with candid investment advice.

Learn more About GMO

Research & Commentary

GMO Quarterly Letter
The 2Q2017 GMO Quarterly Letter features Ben Inker’s “Emerging Value and Margin of Superiority” and Jeremy Grantham’s “Why Are Stock Market Prices So High?”

Updates & Research

China’s Rising Presence in Emerging Debt Markets -- Carl Ross
The Good Thing About Climate Change: Opportunities -- Lucas White and Jeremy Grantham
The S&P 500: Just Say No -- Matt Kadnar and James Montier
Revisiting the Traditional Emerging Market Equities Allocation Framework -- Amit Bhartia and Mehak Dua
Viewpoints - I Do Indeed Believe the US Market Will Revert Toward Its Old Means – Just Very Slowly -- Jeremy Grantham
Six Impossible Things Before Breakfast -- James Montier

Click here for more Research & Commentary

Featured Video

Keeping the Faith in Value Investing
Ben Inker, Co-Head of GMO’s Asset Allocation team, discusses the advantages of long-term valuation-based investing and why GMO is Keeping the Faith in this approach.

To view other additional market commentary and videos, please register with our website. Registering gives you access to information about GMO's strategies as well as the GMO Trust Prospectus, Statement of Additional Information, and annual and semi-annual reports.